Perspective Therapeutics CATX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 2.75 | 104.22 | -0.51 | -39,832 | -37 | |
| 2025Q3 | 3.43 | 107.55 | -0.35 | -27,861 | -26 | |
| 2025Q2 | 3.44 | 109.87 | -0.29 | -24,039 | -21 | |
| 2025Q1 | 2.13 | 120.97 | -0.25 | -21,832 | -18 | |
| 2024Q4 | 3.19 | 106.18 | -0.61 | -44,984 | -40 | |
| 2024Q3 | 13.35 | 123.79 | -0.21 | -18,634 | -15 | |
| 2024Q2 | 9.97 | 127.50 | -0.16 | -14,263 | -12 | |
| 2024Q1 | 11.90 | 110.27 | -0.25 | -13,005 | -12 | |
| 2023Q4 | 4.02 | 100.74 | -0.91 | -11,676 | -25 | |
| 2023Q3 | 2.74 | 101.54 | -0.38 | -13,620 | -10 | |
| 2023Q2 | 6.68 | 103.11 | -0.45 | -9,754 | -11 | |
| 2023Q1 | 6.38 | 103.74 | 0.00 | -9,761 | 0 | |
| 2022Q4 | 2.47 | -0.20 | -3,203 | -3 | ||
| 2022Q3 | 2.30 | 103.44 | -0.30 | -4,208 | -4 | |
| 2022Q2 | 3.09 | 101.35 | -0.10 | -2,106 | -2 | |
| 2022Q1 | 3.63 | 102.15 | -0.10 | -1,376 | -1 | |
| 2021Q4 | 3.88 | 101.93 | -0.10 | -1,635 | -2 | |
| 2020Q1 | 5.30 | 100.55 | -548 | -1 | ||
| 2019Q4 | 6.24 | 100.67 | -903 | -1 | ||
| 2019Q3 | 3.21 | 102.45 | -836 | -1 |